[{"id":"4709cf4b-f7f6-4c8f-8b77-5a8ac8771021","acronym":"","url":"https://clinicaltrials.gov/study/NCT03674411","created_at":"2021-01-18T18:01:23.529Z","updated_at":"2024-07-02T16:35:10.273Z","phase":"Phase 2","brief_title":"Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy","source_id_and_acronym":"NCT03674411","lead_sponsor":"Masonic Cancer Center, University of Minnesota","biomarkers":" FLT3 • NPM1 • KMT2A • HLA-DRB1 • CEBPA","pipe":" | ","alterations":" FLT3-ITD mutation • NPM1 mutation • MLL rearrangement • MLL rearrangement • CEBPA mutation • FLT3 wild-type","tags":["FLT3 • NPM1 • KMT2A • HLA-DRB1 • CEBPA"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e FLT3-ITD mutation • NPM1 mutation • MLL rearrangement • MLL rearrangement • CEBPA mutation • FLT3 wild-type"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • melphalan • fludarabine IV • busulfan • cyclophosphamide intravenous • spanlecortemlocel (MGTA-456)"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 22","initiation":"Initiation: 01/02/2019","start_date":" 01/02/2019","primary_txt":" Primary completion: 06/23/2020","primary_completion_date":" 06/23/2020","study_txt":" Completion: 06/28/2024","study_completion_date":" 06/28/2024","last_update_posted":"2024-04-10"},{"id":"2d0e25a1-48b8-42d8-ab0d-c9af2f7ab8c7","acronym":"","url":"https://clinicaltrials.gov/study/NCT01474681","created_at":"2021-01-18T06:09:06.435Z","updated_at":"2024-07-02T16:36:36.706Z","phase":"Phase 1/2","brief_title":"Safety and Tolerability of HSC835 in Patients With Hematological Malignancies","source_id_and_acronym":"NCT01474681","lead_sponsor":"Novartis Pharmaceuticals","biomarkers":" CD34","pipe":" | ","alterations":" CD34 positive","tags":["CD34"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD34 positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e spanlecortemlocel (MGTA-456)"],"overall_status":"Completed","enrollment":" Enrollment 27","initiation":"Initiation: 01/09/2012","start_date":" 01/09/2012","primary_txt":" Primary completion: 10/03/2016","primary_completion_date":" 10/03/2016","study_txt":" Completion: 10/03/2016","study_completion_date":" 10/03/2016","last_update_posted":"2020-12-30"}]